NASDAQ:KYTX | Balance Sheet | Kyverna Therapeutics, Inc.

Complete source-backed balance-sheet history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$31.81M$167.62M$206.54M$1.33M$3.44M$219.82M$2.93M$22.8M$54.27M$165.55M
2026-03-31$32.19M$204.25M$241.73M$1.34M$5.01M$257.02M$11.6M$29.67M$61.44M$195.58M
2025-12-31$124.09M$155.16M$282.95M$1.55M$4.9M$293.83M$5.31M$36.49M$61.55M$232.28M
2025-09-30$34.16M$136.97M$174.93M$1.79M$5.36M$187.16M$3.02M$33.87M$35.21M$151.95M
2025-06-30$53.44M$158.24M$214.33M$2.16M$4.05M$226.51M$9.92M$39.79M$42.13M$184.38M
2025-03-31$56.87M$185.78M$247.65M$2.44M$3.64M$260.66M$8.47M$33.29M$36.65M$224.01M
2024-12-31$96.62M$189.36M$290.6M$3.35M$2.84M$304.65M$4.62M$33.76M$38.06M$266.59M
2024-09-30$104.66M$216.92M$325.37M$3.15M$1.88M$339.2M$9.93M$30.99M$296,000.00$36.49M$302.71M
2024-06-30$131.62M$214.62M$348.82M$3.37M$1.21M$363.12M$4.86M$23.48M$29.61M$333.51M
2024-03-31$224.29M$145.51M$375.49M$2.71M$1.17M$389.98M$7.45M$21.87M$28.99M$360.99M
2023-12-31$34.65M$22.9M$60.66M$2.33M$3.36M$75.2M$4.36M$19.86M$26.02M-$13.14M
2023-09-30$22.97M-$111.81M
2023-06-30$53.43M-$97.2M
2023-03-31$39.79M-$84.61M
2022-12-31-$74M